Clinical Trial Detail

NCT ID NCT03473639
Title A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy (Breast 49)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors University of Virginia
Indications

Her2-receptor negative breast cancer

Therapies

Capecitabine + Entinostat

Age Groups: adult senior

Additional content available in CKB BOOST